Pricing Log in Create free account

Mirum Pharmaceuticals, Inc. (MIRM) vs Travere Therapeutics, Inc. (TVTX)

Mirum Pharmaceuticals, Inc. and Travere Therapeutics, Inc. are both Biotechnology companies. Mirum Pharmaceuticals, Inc. and Travere Therapeutics, Inc. are of similar size ($5.4B and $5.0B). Travere Therapeutics, Inc. grew revenue faster over the last twelve months: 77.1% against 44.0%. Travere Therapeutics, Inc. has the higher net margin (−7.35% vs −139.2%) and the higher return on invested capital (−18.3% vs −173.0%). Across the 16 metrics below, Travere Therapeutics, Inc. leads on 14 and Mirum Pharmaceuticals, Inc. on 2.

Valuation

Metric MIRM TVTX Biotechnology median
P/E n/m n/m 8.50
P/S 8.22 7.84 9.71
P/B n/m 189.16 2.13
Price to free cash flow n/m 320.51 20.82
EV/EBITDA n/m 236.26 0.64
EV/Sales 8.73 8.04 9.21
Earnings yield (18.13%) (0.91%) (33.15%)
Free cash flow yield (5.39%) 0.31% (25.50%)

Profitability

Metric MIRM TVTX Biotechnology median
Gross margin 81.72% 98.60% 65.16%
Operating margin (134.93%) (6.84%) 0.00%
Net margin (139.18%) (7.35%) 0.00%
Free cash flow margin (44.29%) 2.56% 0.00%
Return on equity (702.97%) (151.79%) (56.36%)
Return on assets (97.15%) (6.42%) (48.04%)
Return on invested capital (172.96%) (18.31%) 0.00%

Growth

Metric MIRM TVTX Biotechnology median
Revenue growth (TTM) 44.02% 77.12% 6.02%
EPS growth (last fiscal year) 74.59% 92.89% 30.26%
Revenue growth, 5-year CAGR — 19.87% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MIRM TVTX Biotechnology median
Debt to equity (71.97) 24.58 0.00
Current ratio 2.86 4.05 4.72
Net debt to EBITDA (19.11) 2.27 0.96

Dividend

Metric MIRM TVTX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric MIRM TVTX Biotechnology median
Market cap 5.35b 4.98b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack